{
  "ticker": "LLY",
  "target_date": "2025-03-12",
  "actual_date": "2025-03-12",
  "collected_at": "2025-12-08T11:30:31.302495",
  "price": {
    "open": 810.31,
    "high": 829.9,
    "low": 808.63,
    "close": 817.1812133789062,
    "volume": 3014800,
    "change_1d_pct": -0.27,
    "change_7d_pct": -11.6,
    "change_30d_pct": 2.27
  },
  "technicals": {
    "rsi_14": 38.43,
    "sma_20": 875.47,
    "sma_50": 823.62,
    "macd": 5.19,
    "macd_signal": 18.444,
    "macd_histogram": -13.254,
    "bb_upper": 943.63,
    "bb_lower": 807.31,
    "price_vs_sma20_pct": -6.66,
    "price_vs_sma50_pct": -0.78,
    "volume_ratio": 0.83
  },
  "fundamentals": {
    "market_cap": 890767867904,
    "pe_ratio": 48.684666,
    "forward_pe": 43.850574,
    "price_to_book": 37.41167,
    "price_to_sales": 14.991096,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.64,
    "pct_from_52w_low": 59.3
  },
  "macro": {
    "spy": {
      "price": 554.02,
      "change_1d_pct": 0.53,
      "change_7d_pct": -3.12
    },
    "vix": {
      "level": 24.23,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.32
    },
    "dollar_index": {
      "level": 103.61
    },
    "gold": {
      "price": 2939.1
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know",
      "source": "Yahoo",
      "datetime": 1741815914,
      "summary": "In the most recent trading session, Eli Lilly (LLY) closed at $822.27, indicating a -0.22% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=c7a4d0d1e0e4a78e409315dd99691013188864acffeb069cbb82773d529bc534"
    },
    {
      "headline": "Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion",
      "source": "Yahoo",
      "datetime": 1741810157,
      "summary": "Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.",
      "url": "https://finnhub.io/api/news?id=9d4ec59f6037fefdbdcd47a67f7600dc71ffa187ce9b258dd50d70a5e8a54a3c"
    },
    {
      "headline": "Roche, Zealand sign deal: What it means for weight loss drug space",
      "source": "Yahoo",
      "datetime": 1741809792,
      "summary": "Roche (ROG.SW) and Zealand Pharma (ZEAL.CO) stocks are in focus after the company announced an agreement to make amylin, an obesity drug, in a deal valued at $5.3 billion. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination Co-Hosts Julie Hyman and Josh Lipton to examine wh",
      "url": "https://finnhub.io/api/news?id=f4a3b102142b36e27741b33f9ca4f26a5b985f6d88b256a6bed94ed4aeb3dba3"
    },
    {
      "headline": "Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds?",
      "source": "Yahoo",
      "datetime": 1741803925,
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town [\u2026]",
      "url": "https://finnhub.io/api/news?id=96c48fc5a3a99e5cfe6794ec33f20ae48ae575926964a8dead9639d33c26f5f0"
    },
    {
      "headline": "Novo Nordisk Is Falling.\u00a0Competition Is a Killer.",
      "source": "Yahoo",
      "datetime": 1741803780,
      "summary": "Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.",
      "url": "https://finnhub.io/api/news?id=eb7bd3d62860d21b04cc822bd5b0942feaae2c3e6f932d000ba662f04880b544"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-04",
      "description": "xslF345X05/form4-03042025_040301.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038785.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038712.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/form4-02262025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"
    },
    {
      "form": "4",
      "date": "2025-02-25",
      "description": "xslF345X05/form4-02252025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005456/xslF345X05/form4-02252025_040201.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}